E-LIB Suche - Ergebnisse für: Venugopal, Sangeetha

1

Oral decitabine plus cedazuridine and venetoclax in patient..:

Bataller, Alex ; Montalban-Bravo, Guillermo ; Bazinet, Alexandre...
The Lancet Haematology. 11 (2024) 3 - p. e186-e195 , 2024

Link: https://doi.org/10.1016/..

2

Venetoclax and hypomethylating agents in octogenarians and ..:

Madarang, Ellen ; Lykon, Jillian ; Zhao, Wei...
Blood Neoplasia. 1 (2024) 2 - p. 100016 , 2024

Link: https://doi.org/10.1016/..

3

Clinical outcomes associated with NPM1 mutations in patient..:

Issa, Ghayas C. ; Bidikian, Aram ; Venugopal, Sangeetha...
Blood Advances. 7 (2023) 6 - p. 933-942 , 2023

Link: https://doi.org/10.1182/..

4

Trying to outRun‐DIC in KMT2Ar AML: It's tricky:

Venugopal, Sangeetha ; Taylor, Justin
Cancer. 129 (2023) 12 - p. 1797-1799 , 2023

Link: https://doi.org/10.1002/..

5

P723: CLINICAL AND MOLECULAR ASSOCIATIONS WITH OUTCOMES IN ..:

Bazinet, Alexandre ; Prasad Desikan, Sai ; LI, Ziyi...
HemaSphere. 7 (2023) S3 - p. e554617b , 2023

Link: https://doi.org/10.1097/..

6

Targeted therapy with the mutant IDH2 inhibitor enasidenib ..:

DiNardo, Courtney D. ; Venugopal, Sangeetha ; Lachowiez, Curtis...
Blood Advances. 7 (2023) 11 - p. 2378-2387 , 2023

Link: https://doi.org/10.1182/..

7

S172: PHASE 1/2 STUDY OF ORAL DECITABINE/CEDAZURIDINE IN CO..:

Bataller, Alex ; Bazinet, Alexandre ; Venugopal, Sangeetha...
HemaSphere. 7 (2023) S3 - p. e18588ff , 2023

Link: https://doi.org/10.1097/..

8

Olutasidenib: from bench to bedside:

Venugopal, Sangeetha ; Watts, Justin
Blood Advances. 7 (2023) 16 - p. 4358-4365 , 2023

Link: https://doi.org/10.1182/..

9

Poster: MDS-520 A Phase I/II Study of Venetoclax in Combina..:

Venugopal, Sangeetha ; Kantarjian, Hagop ; Maiti, Abhishek...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S150 , 2022

Link: https://doi.org/10.1016/..

10

A retrospective study of cladribine and low‐dose cytarabine..:

Bazinet, Alexandre ; Darbaniyan, Faezeh ; Kadia, Tapan M....
Cancer. 129 (2022) 4 - p. 560-568 , 2022

Link: https://doi.org/10.1002/..

11

Differential prognostic impact of RUNX1 mutations according..:

Venugopal, Sangeetha ; DiNardo, Courtney D. ; Loghavi, Sanam...
American Journal of Hematology. 97 (2022) 12 - p. 1560-1567 , 2022

Link: https://doi.org/10.1002/..

12

Efficacy and safety of enasidenib and azacitidine combinati..:

Venugopal, Sangeetha ; Takahashi, Koichi ; Daver, Naval...
Blood Cancer Journal. 12 (2022) 1 - p. , 2022

Link: https://doi.org/10.1038/..

13

Impact of frontline treatment approach on outcomes in patie..:

Short, Nicholas J. ; Venugopal, Sangeetha ; Qiao, Wei...
Journal of Hematology & Oncology. 15 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..

14

Validation of ALFA 1200 score in patients with AML >60 year..:

Venugopal, Sangeetha ; Borthakur, Gautam ; Daver, Naval...
Blood Advances. 6 (2022) 19 - p. 5546-5549 , 2022

Link: https://doi.org/10.1182/..

15

MDS-520 A Phase I/II Study of Venetoclax in Combination Wit..:

Venugopal, Sangeetha ; Kantarjian, Hagop ; Maiti, Abhishek...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S321 , 2022

Link: https://doi.org/10.1016/..